Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the use of chemotherapy combinations in the frontline treatment of advanced ovarian cancer
- Cite recent clinical trial results regarding the treatment of patients with platinum-sensitive recurrent ovarian cancer
- Summarize clinical trial data from studies of chemotherapy and targeted agents for the treatment of platinum-resistant ovarian cancer
CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.